Press Releases
   Company Newsletter
   Media Coverage
   Special Events
   
     
 
   
 

Sabinsa Corporation is Awarded Thomas Alva Edison Patent Award

 
 

November 23rd, 2004

 
 

Piscataway, NJ: Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded the Research & Development Council of New Jersey's 2004 Thomas Alva Edison Patent Award in the Consumer/Small Company category for its U.S. Patent #5,804,596, "Method of preparing a forskolin composition for use in promoting lean body mass and treating mood disorders".  The Thomas Alva Edison Patent Awards, which recognize the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey, were presented at the Council's annual fall dinner on November 11, 2004, at the Liberty Science Center in Jersey City, NJ. On behalf of Sabinsa Corporation Dr. Vladimir Badmaev, Vice President of Medical & Scientific Affairs, accepted the award from Dr. Robert J. Schaffhauser, Chairman of the Research & Development Council of New Jersey.

Companies throughout New Jersey were invited to submit patents for consideration for the Thomas Alva Edison Patent Awards.  Each patent was reviewed thoroughly by the Council, which is comprised of senior representatives from industry, academia and government.  Winners were then chosen based on their exceptional merit.  Other 2004 award winners include Celgene Corporation, Engelhard Corporation, ExxonMobil Research & Engineering, International Specialty Products, Merck & Co., Inc., Princeton University, Rutgers University, Schering-Plough Research Institute and Wyeth to name a few. 

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of high quality herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Over the past nine years, Sabinsa has brought to market more than thirty standardized botanical extracts, including ForsLean.  ForsLean is an extract of Coleus forskohlii root, which contains high levels of forskolin, a compound that has been shown to increase lean body mass and promote weight loss.  Sabinsa has secured a patent for the use of forskolin as a weight management ingredient and manufactures and supplies various extract strengths for use in a variety of supplements and products. In cosmetic formulations Forslean® is used as a skin conditioning agent & helps to build up the skin matrix and effectively helps in skin firming and anti-aging effects. For more information visit www.forslean.com .

The Research and Development Council of New Jersey is a non-profit organization dedicated to cultivating an environment that supports the advancement of research and development throughout New Jersey.  The Council is comprised of senior representatives from industry, academia and government. In fact, many R&D Council members represent today's Fortune 100 companies.  For more information visit www.rdnj.org .
 
  Contact: Dr. Vladimir Badmaev
Tel: 732-777-1111; Fax: 732-777-1443
E-mail: info@sabinsa.com
 
   
Copyright © 2007 Sabinsa Corporation All Rights Reserved